| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA Polymerase II | 62 | 2026 | 350 | 11.330 |
Why?
|
| Transcription, Genetic | 65 | 2026 | 1454 | 7.380 |
Why?
|
| RNA Precursors | 18 | 2025 | 154 | 5.060 |
Why?
|
| RNA, Messenger | 36 | 2025 | 2805 | 3.730 |
Why?
|
| RNA Processing, Post-Transcriptional | 16 | 2021 | 90 | 3.490 |
Why?
|
| Transcription Termination, Genetic | 5 | 2025 | 22 | 3.300 |
Why?
|
| RNA Splicing | 17 | 2023 | 284 | 2.430 |
Why?
|
| Transcription Elongation, Genetic | 6 | 2018 | 24 | 2.210 |
Why?
|
| Saccharomyces cerevisiae Proteins | 13 | 2017 | 414 | 2.100 |
Why?
|
| Nuclear Proteins | 13 | 2025 | 740 | 2.080 |
Why?
|
| Alternative Splicing | 9 | 2025 | 248 | 2.020 |
Why?
|
| RNA-Binding Proteins | 12 | 2025 | 447 | 2.020 |
Why?
|
| Promoter Regions, Genetic | 19 | 2026 | 1247 | 1.890 |
Why?
|
| Histones | 9 | 2018 | 666 | 1.690 |
Why?
|
| Poly A | 9 | 2022 | 50 | 1.690 |
Why?
|
| Transcriptional Elongation Factors | 6 | 2022 | 39 | 1.590 |
Why?
|
| Saccharomyces cerevisiae | 12 | 2022 | 574 | 1.560 |
Why?
|
| Chromatin | 9 | 2025 | 553 | 1.540 |
Why?
|
| Protein Phosphatase 1 | 2 | 2025 | 32 | 1.480 |
Why?
|
| Exoribonucleases | 4 | 2019 | 43 | 1.420 |
Why?
|
| Cyclin-Dependent Kinases | 9 | 2025 | 122 | 1.300 |
Why?
|
| DNA-Binding Proteins | 11 | 2025 | 1482 | 1.210 |
Why?
|
| RNA 3' End Processing | 6 | 2018 | 11 | 1.200 |
Why?
|
| HEK293 Cells | 11 | 2025 | 741 | 1.100 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 7 | 2018 | 28 | 0.970 |
Why?
|
| Transcriptional Activation | 5 | 2018 | 372 | 0.870 |
Why?
|
| RNA | 7 | 2021 | 912 | 0.850 |
Why?
|
| Phosphorylation | 16 | 2025 | 1708 | 0.850 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2019 | 473 | 0.840 |
Why?
|
| Polyadenylation | 3 | 2022 | 39 | 0.790 |
Why?
|
| RNA Caps | 8 | 2014 | 32 | 0.790 |
Why?
|
| Mutation | 26 | 2022 | 4090 | 0.740 |
Why?
|
| Genome, Human | 9 | 2026 | 422 | 0.690 |
Why?
|
| Kinetics | 7 | 2025 | 1568 | 0.660 |
Why?
|
| Transcription Factor TFIIH | 6 | 2020 | 40 | 0.660 |
Why?
|
| Transcription Initiation, Genetic | 2 | 2018 | 19 | 0.650 |
Why?
|
| Cell Line | 19 | 2025 | 2823 | 0.610 |
Why?
|
| HeLa Cells | 11 | 2025 | 632 | 0.590 |
Why?
|
| Chromatin Assembly and Disassembly | 3 | 2017 | 108 | 0.580 |
Why?
|
| DNA, Fungal | 2 | 2017 | 76 | 0.580 |
Why?
|
| Models, Genetic | 8 | 2015 | 527 | 0.580 |
Why?
|
| Introns | 5 | 2023 | 256 | 0.580 |
Why?
|
| Transcription Factors | 13 | 2012 | 1736 | 0.580 |
Why?
|
| RNA Cleavage | 1 | 2018 | 10 | 0.570 |
Why?
|
| Whole Genome Sequencing | 7 | 2026 | 178 | 0.560 |
Why?
|
| Yeasts | 5 | 2011 | 52 | 0.520 |
Why?
|
| RNA, Catalytic | 2 | 2009 | 191 | 0.490 |
Why?
|
| RNA Splice Sites | 4 | 2025 | 51 | 0.490 |
Why?
|
| Nucleosomes | 2 | 2011 | 163 | 0.490 |
Why?
|
| Cell Nucleus | 6 | 2022 | 588 | 0.480 |
Why?
|
| Methyltransferases | 3 | 2004 | 75 | 0.470 |
Why?
|
| Repressor Proteins | 5 | 2025 | 429 | 0.460 |
Why?
|
| Humans | 90 | 2026 | 145763 | 0.460 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2016 | 666 | 0.460 |
Why?
|
| Transcription Factors, TFII | 5 | 2012 | 44 | 0.440 |
Why?
|
| Protein Engineering | 1 | 2016 | 122 | 0.430 |
Why?
|
| Exons | 11 | 2021 | 364 | 0.430 |
Why?
|
| Polymerase Chain Reaction | 4 | 2021 | 1043 | 0.430 |
Why?
|
| RNA Polymerase III | 3 | 2025 | 34 | 0.420 |
Why?
|
| DNA Polymerase II | 3 | 2005 | 35 | 0.420 |
Why?
|
| RNA, Fungal | 2 | 2011 | 67 | 0.420 |
Why?
|
| Binding Sites | 11 | 2019 | 1311 | 0.420 |
Why?
|
| Terminator Regions, Genetic | 5 | 2006 | 13 | 0.410 |
Why?
|
| Exonucleases | 2 | 2022 | 9 | 0.400 |
Why?
|
| Genes, myc | 5 | 2007 | 51 | 0.390 |
Why?
|
| Protein Binding | 7 | 2025 | 2240 | 0.380 |
Why?
|
| RNA Stability | 2 | 2012 | 107 | 0.380 |
Why?
|
| Oocytes | 10 | 2005 | 185 | 0.380 |
Why?
|
| Nucleotidyltransferases | 4 | 2004 | 29 | 0.380 |
Why?
|
| Animals | 40 | 2026 | 38097 | 0.370 |
Why?
|
| Protein Kinases | 3 | 2010 | 312 | 0.370 |
Why?
|
| Genes, Fungal | 2 | 2010 | 55 | 0.360 |
Why?
|
| Gene Expression Regulation, Fungal | 4 | 2017 | 78 | 0.350 |
Why?
|
| Protein Structure, Tertiary | 10 | 2015 | 855 | 0.350 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 2009 | 66 | 0.340 |
Why?
|
| Fungal Proteins | 5 | 2011 | 143 | 0.330 |
Why?
|
| Phosphoserine | 1 | 2010 | 25 | 0.320 |
Why?
|
| Receptors, Progesterone | 2 | 2025 | 244 | 0.320 |
Why?
|
| Neoplasm Proteins | 3 | 2007 | 442 | 0.310 |
Why?
|
| Dichlororibofuranosylbenzimidazole | 6 | 2009 | 8 | 0.300 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2022 | 76 | 0.300 |
Why?
|
| Histone-Lysine N-Methyltransferase | 3 | 2017 | 141 | 0.300 |
Why?
|
| RNA Folding | 2 | 2021 | 35 | 0.290 |
Why?
|
| Spliceosomes | 3 | 2023 | 54 | 0.290 |
Why?
|
| Genes, Regulator | 3 | 2004 | 35 | 0.280 |
Why?
|
| Molecular Sequence Data | 15 | 2014 | 2883 | 0.280 |
Why?
|
| Genetic Variation | 5 | 2026 | 976 | 0.270 |
Why?
|
| Ovarian Neoplasms | 5 | 2015 | 595 | 0.250 |
Why?
|
| Genomics | 5 | 2026 | 830 | 0.230 |
Why?
|
| Ubiquitination | 2 | 2024 | 119 | 0.230 |
Why?
|
| Macromolecular Substances | 5 | 2010 | 216 | 0.230 |
Why?
|
| Peptide Elongation Factors | 2 | 2022 | 15 | 0.220 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2025 | 120 | 0.220 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2017 | 1450 | 0.210 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 2025 | 50 | 0.210 |
Why?
|
| RNA, Transfer | 1 | 2025 | 143 | 0.210 |
Why?
|
| Lysine | 1 | 2007 | 305 | 0.210 |
Why?
|
| RNA Cap-Binding Proteins | 1 | 2004 | 3 | 0.210 |
Why?
|
| DNA, Neoplasm | 2 | 2015 | 160 | 0.200 |
Why?
|
| DNA-Directed RNA Polymerases | 2 | 1997 | 62 | 0.200 |
Why?
|
| Gene Expression Regulation | 9 | 2025 | 2601 | 0.200 |
Why?
|
| Base Sequence | 14 | 2015 | 2171 | 0.200 |
Why?
|
| Interferons | 1 | 2025 | 186 | 0.200 |
Why?
|
| RNA Editing | 3 | 2009 | 26 | 0.200 |
Why?
|
| Methylation | 3 | 2011 | 242 | 0.190 |
Why?
|
| Nucleic Acid Conformation | 2 | 2025 | 723 | 0.190 |
Why?
|
| Amino Acid Sequence | 9 | 2014 | 2131 | 0.190 |
Why?
|
| Models, Biological | 5 | 2020 | 1764 | 0.190 |
Why?
|
| RNA, Antisense | 1 | 2022 | 18 | 0.190 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2012 | 139 | 0.190 |
Why?
|
| Models, Theoretical | 1 | 2006 | 560 | 0.180 |
Why?
|
| Immunoglobulin Variable Region | 3 | 2017 | 80 | 0.180 |
Why?
|
| Signal Transduction | 5 | 2025 | 5223 | 0.180 |
Why?
|
| Progestins | 2 | 2025 | 66 | 0.180 |
Why?
|
| Nucleotides | 1 | 2022 | 129 | 0.180 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2025 | 981 | 0.170 |
Why?
|
| Medical Oncology | 1 | 2024 | 340 | 0.170 |
Why?
|
| Ultraviolet Rays | 2 | 2018 | 385 | 0.170 |
Why?
|
| Gene Products, tat | 2 | 1998 | 22 | 0.170 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2003 | 130 | 0.170 |
Why?
|
| Mice | 15 | 2018 | 18355 | 0.170 |
Why?
|
| Rare Diseases | 1 | 2021 | 116 | 0.160 |
Why?
|
| HCT116 Cells | 2 | 2018 | 76 | 0.160 |
Why?
|
| Breast Neoplasms | 6 | 2025 | 2393 | 0.160 |
Why?
|
| Proto-Oncogenes | 3 | 1989 | 28 | 0.160 |
Why?
|
| Nerve Tissue Proteins | 3 | 2022 | 592 | 0.160 |
Why?
|
| Transfection | 7 | 2007 | 927 | 0.160 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 2 | 2014 | 64 | 0.160 |
Why?
|
| Xenopus | 6 | 2003 | 87 | 0.160 |
Why?
|
| HIV-2 | 2 | 1997 | 18 | 0.160 |
Why?
|
| Adenosine Triphosphatases | 2 | 2012 | 159 | 0.150 |
Why?
|
| Peptide Chain Elongation, Translational | 2 | 1998 | 18 | 0.150 |
Why?
|
| 3' Flanking Region | 1 | 2018 | 7 | 0.140 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 2 | 2009 | 12 | 0.140 |
Why?
|
| Host-Pathogen Interactions | 1 | 2022 | 361 | 0.140 |
Why?
|
| Phenanthrenes | 1 | 2018 | 12 | 0.140 |
Why?
|
| Metallothionein | 1 | 1998 | 25 | 0.140 |
Why?
|
| Hydrolysis | 2 | 2011 | 197 | 0.140 |
Why?
|
| Diterpenes | 1 | 2018 | 26 | 0.140 |
Why?
|
| Coloboma | 1 | 2018 | 5 | 0.140 |
Why?
|
| Epoxy Compounds | 1 | 2018 | 31 | 0.140 |
Why?
|
| Coenzymes | 1 | 1998 | 19 | 0.140 |
Why?
|
| Isotonic Solutions | 1 | 2018 | 42 | 0.140 |
Why?
|
| PAX6 Transcription Factor | 1 | 2018 | 21 | 0.140 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2018 | 43 | 0.140 |
Why?
|
| Fragile X Syndrome | 2 | 2007 | 119 | 0.140 |
Why?
|
| Nystagmus, Pathologic | 1 | 2018 | 19 | 0.140 |
Why?
|
| Genes | 6 | 2004 | 228 | 0.140 |
Why?
|
| Down Syndrome | 1 | 2025 | 525 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2017 | 625 | 0.130 |
Why?
|
| Cell Line, Tumor | 7 | 2025 | 3551 | 0.130 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 1 | 2017 | 10 | 0.130 |
Why?
|
| Zebrafish Proteins | 1 | 2001 | 314 | 0.130 |
Why?
|
| Cell Cycle Proteins | 3 | 2003 | 630 | 0.130 |
Why?
|
| Cytidine Deaminase | 2 | 2017 | 59 | 0.130 |
Why?
|
| Receptors, Estrogen | 2 | 2017 | 404 | 0.130 |
Why?
|
| 3' Untranslated Regions | 3 | 2022 | 149 | 0.130 |
Why?
|
| Serine | 3 | 2009 | 143 | 0.130 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2017 | 86 | 0.130 |
Why?
|
| Enzyme Inhibitors | 2 | 2003 | 821 | 0.130 |
Why?
|
| Trans-Activators | 2 | 2002 | 396 | 0.130 |
Why?
|
| Xenopus laevis | 4 | 2004 | 104 | 0.120 |
Why?
|
| Neoplasms | 4 | 2024 | 2913 | 0.120 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2015 | 45 | 0.120 |
Why?
|
| Plasmids | 5 | 2006 | 373 | 0.120 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2016 | 22 | 0.120 |
Why?
|
| Brain Neoplasms | 2 | 2015 | 1331 | 0.110 |
Why?
|
| Drosophila Proteins | 2 | 2003 | 214 | 0.110 |
Why?
|
| Spinal Neoplasms | 1 | 2015 | 37 | 0.110 |
Why?
|
| Tetraploidy | 1 | 2015 | 4 | 0.110 |
Why?
|
| Protein Domains | 1 | 2017 | 311 | 0.110 |
Why?
|
| Cataract | 1 | 2018 | 238 | 0.110 |
Why?
|
| Critical Illness | 1 | 2022 | 900 | 0.110 |
Why?
|
| Clonal Evolution | 1 | 2015 | 47 | 0.110 |
Why?
|
| Genes, p53 | 1 | 2015 | 67 | 0.110 |
Why?
|
| Chromosomes, Human | 1 | 2015 | 44 | 0.110 |
Why?
|
| Recombinational DNA Repair | 1 | 2015 | 19 | 0.110 |
Why?
|
| Genome-Wide Association Study | 4 | 2022 | 1430 | 0.110 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2015 | 90 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2007 | 267 | 0.110 |
Why?
|
| HIV-1 | 2 | 1998 | 908 | 0.110 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2015 | 534 | 0.110 |
Why?
|
| X Chromosome | 2 | 1991 | 66 | 0.110 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2015 | 72 | 0.110 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2015 | 104 | 0.100 |
Why?
|
| Immunoglobulin M | 1 | 2015 | 265 | 0.100 |
Why?
|
| CRISPR-Cas Systems | 1 | 2016 | 166 | 0.100 |
Why?
|
| Escherichia coli Proteins | 1 | 2016 | 201 | 0.100 |
Why?
|
| Granulomatous Disease, Chronic | 2 | 1991 | 49 | 0.100 |
Why?
|
| Lymphocytes | 1 | 2015 | 376 | 0.100 |
Why?
|
| Histone Chaperones | 1 | 2013 | 15 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase 9 | 2 | 2012 | 18 | 0.100 |
Why?
|
| State Medicine | 2 | 2024 | 26 | 0.100 |
Why?
|
| Deoxycytidine | 2 | 2015 | 220 | 0.100 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2013 | 52 | 0.100 |
Why?
|
| Antibodies | 4 | 2006 | 397 | 0.100 |
Why?
|
| Long QT Syndrome | 1 | 2014 | 68 | 0.100 |
Why?
|
| Gene Amplification | 2 | 2003 | 118 | 0.100 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 3 | 1997 | 35 | 0.100 |
Why?
|
| Potassium Channels | 1 | 2014 | 148 | 0.100 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2013 | 89 | 0.090 |
Why?
|
| Time Factors | 5 | 2017 | 7133 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 5 | 2015 | 778 | 0.090 |
Why?
|
| United Kingdom | 2 | 2024 | 358 | 0.090 |
Why?
|
| Globins | 3 | 1997 | 21 | 0.090 |
Why?
|
| Sequence Deletion | 2 | 2003 | 191 | 0.090 |
Why?
|
| Quantitative Trait Loci | 1 | 2014 | 381 | 0.090 |
Why?
|
| DNA | 6 | 2005 | 1437 | 0.090 |
Why?
|
| Ovary | 1 | 2013 | 234 | 0.090 |
Why?
|
| beta-Globins | 1 | 2011 | 8 | 0.090 |
Why?
|
| Chromosome Deletion | 5 | 2001 | 126 | 0.090 |
Why?
|
| Carcinogenesis | 1 | 2013 | 228 | 0.090 |
Why?
|
| Protein Interaction Mapping | 1 | 2012 | 105 | 0.090 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2011 | 23 | 0.090 |
Why?
|
| Escherichia coli | 1 | 2016 | 835 | 0.090 |
Why?
|
| Glioblastoma | 1 | 2015 | 354 | 0.080 |
Why?
|
| Plasma | 1 | 2013 | 223 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2009 | 169 | 0.080 |
Why?
|
| Repetitive Sequences, Amino Acid | 2 | 2001 | 19 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 426 | 0.080 |
Why?
|
| Recombinant Proteins | 4 | 1998 | 1368 | 0.080 |
Why?
|
| Chromatography, Affinity | 2 | 2002 | 80 | 0.080 |
Why?
|
| Isoquinolines | 2 | 2004 | 43 | 0.080 |
Why?
|
| DNA Helicases | 3 | 1997 | 136 | 0.080 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 1990 | 23 | 0.080 |
Why?
|
| RNA, Untranslated | 1 | 2011 | 121 | 0.080 |
Why?
|
| Female | 21 | 2025 | 79035 | 0.080 |
Why?
|
| Genes, Reporter | 2 | 2003 | 277 | 0.080 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2010 | 106 | 0.080 |
Why?
|
| Hepatitis Delta Virus | 1 | 2009 | 7 | 0.080 |
Why?
|
| Cricetulus | 1 | 2009 | 118 | 0.070 |
Why?
|
| Myocytes, Cardiac | 1 | 2014 | 546 | 0.070 |
Why?
|
| Fluorouracil | 1 | 2010 | 231 | 0.070 |
Why?
|
| CHO Cells | 1 | 2009 | 169 | 0.070 |
Why?
|
| Positive Transcriptional Elongation Factor B | 2 | 2017 | 29 | 0.070 |
Why?
|
| Fibronectins | 3 | 2009 | 136 | 0.070 |
Why?
|
| Cricetinae | 1 | 2009 | 305 | 0.070 |
Why?
|
| Epithelial Cells | 1 | 2015 | 1134 | 0.070 |
Why?
|
| Adenosine Deaminase | 2 | 2007 | 43 | 0.070 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2009 | 56 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 777 | 0.070 |
Why?
|
| Epilepsy | 1 | 2014 | 390 | 0.070 |
Why?
|
| Transcription Initiation Site | 1 | 2009 | 43 | 0.070 |
Why?
|
| RNA Transport | 1 | 2008 | 27 | 0.070 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2008 | 117 | 0.070 |
Why?
|
| Rabbits | 2 | 2002 | 653 | 0.070 |
Why?
|
| Phosphoproteins | 1 | 1990 | 337 | 0.070 |
Why?
|
| Carcinoma | 2 | 2015 | 227 | 0.070 |
Why?
|
| Ribonucleoproteins | 1 | 2008 | 89 | 0.070 |
Why?
|
| Amanitins | 2 | 2004 | 4 | 0.070 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 2 | 1998 | 25 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2013 | 883 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2014 | 1166 | 0.060 |
Why?
|
| Bacteroides | 1 | 2007 | 20 | 0.060 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2017 | 191 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2020 | 762 | 0.060 |
Why?
|
| Mutant Proteins | 1 | 2007 | 105 | 0.060 |
Why?
|
| Cell Nucleus Structures | 1 | 2006 | 3 | 0.060 |
Why?
|
| Replication Origin | 2 | 2002 | 18 | 0.060 |
Why?
|
| Oncogenes | 1 | 1986 | 118 | 0.060 |
Why?
|
| Allosteric Regulation | 1 | 2006 | 99 | 0.060 |
Why?
|
| Transcription Factor TFIIIB | 1 | 2025 | 5 | 0.060 |
Why?
|
| Heterozygote | 1 | 2007 | 314 | 0.060 |
Why?
|
| Lung Neoplasms | 3 | 2015 | 2667 | 0.060 |
Why?
|
| Receptors, AMPA | 1 | 2007 | 147 | 0.060 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2025 | 21 | 0.060 |
Why?
|
| Africa | 1 | 2026 | 119 | 0.060 |
Why?
|
| Binding Sites, Antibody | 2 | 1982 | 40 | 0.060 |
Why?
|
| Substrate Specificity | 2 | 1997 | 387 | 0.060 |
Why?
|
| Uracil | 1 | 2005 | 36 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2015 | 2181 | 0.060 |
Why?
|
| Ireland | 1 | 2024 | 32 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2015 | 1969 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2007 | 354 | 0.050 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2004 | 16 | 0.050 |
Why?
|
| Hematology | 1 | 2024 | 21 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 3 | 2017 | 887 | 0.050 |
Why?
|
| England | 1 | 2024 | 110 | 0.050 |
Why?
|
| Physical Chromosome Mapping | 1 | 2004 | 21 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2004 | 20 | 0.050 |
Why?
|
| Genes, cdc | 1 | 2004 | 11 | 0.050 |
Why?
|
| DNA Repair | 2 | 1997 | 255 | 0.050 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 2001 | 117 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1996 | 141 | 0.050 |
Why?
|
| Pedigree | 2 | 2018 | 515 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 2000 | 0.050 |
Why?
|
| Genetic Testing | 1 | 2007 | 483 | 0.050 |
Why?
|
| Intestines | 1 | 2007 | 354 | 0.050 |
Why?
|
| Information Dissemination | 1 | 2026 | 224 | 0.050 |
Why?
|
| Cloning, Molecular | 3 | 1991 | 538 | 0.050 |
Why?
|
| BRCA2 Protein | 1 | 2003 | 68 | 0.050 |
Why?
|
| Phenotype | 3 | 2018 | 3170 | 0.050 |
Why?
|
| Antineoplastic Agents | 2 | 2013 | 2219 | 0.050 |
Why?
|
| DNA Mutational Analysis | 2 | 2015 | 410 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2024 | 194 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2003 | 219 | 0.050 |
Why?
|
| RNA, Small Nuclear | 1 | 2003 | 40 | 0.050 |
Why?
|
| Simian virus 40 | 1 | 2002 | 24 | 0.050 |
Why?
|
| Interleukin-10 Receptor beta Subunit | 1 | 2022 | 1 | 0.050 |
Why?
|
| Cells, Cultured | 4 | 2007 | 4151 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 22 | 2 | 2001 | 48 | 0.050 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2022 | 7 | 0.050 |
Why?
|
| Mucin-1 | 1 | 2022 | 21 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2003 | 563 | 0.040 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2002 | 37 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2010 | 868 | 0.040 |
Why?
|
| Operon | 1 | 1982 | 67 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2022 | 59 | 0.040 |
Why?
|
| E-Selectin | 1 | 2022 | 61 | 0.040 |
Why?
|
| Fucosyltransferases | 1 | 2022 | 33 | 0.040 |
Why?
|
| Precision Medicine | 1 | 2026 | 461 | 0.040 |
Why?
|
| Factor VIII | 1 | 2022 | 106 | 0.040 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2022 | 117 | 0.040 |
Why?
|
| Human Genome Project | 1 | 2001 | 15 | 0.040 |
Why?
|
| Ribonucleases | 2 | 2003 | 48 | 0.040 |
Why?
|
| Templates, Genetic | 2 | 1996 | 63 | 0.040 |
Why?
|
| HL-60 Cells | 1 | 2020 | 30 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2022 | 181 | 0.040 |
Why?
|
| Neoplasm Metastasis | 2 | 2015 | 688 | 0.040 |
Why?
|
| Peptide Fragments | 4 | 1998 | 696 | 0.040 |
Why?
|
| Family Characteristics | 1 | 2021 | 197 | 0.040 |
Why?
|
| DNA, Plant | 1 | 1999 | 17 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 1999 | 25 | 0.040 |
Why?
|
| Chromosome Mapping | 3 | 2001 | 507 | 0.040 |
Why?
|
| Child | 4 | 2024 | 22739 | 0.040 |
Why?
|
| Adult | 7 | 2021 | 40872 | 0.040 |
Why?
|
| Minichromosome Maintenance Complex Component 2 | 1 | 1999 | 3 | 0.040 |
Why?
|
| Genes, Plant | 1 | 1999 | 46 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2022 | 372 | 0.040 |
Why?
|
| Holoenzymes | 1 | 1999 | 25 | 0.040 |
Why?
|
| RNA Helicases | 1 | 1999 | 27 | 0.040 |
Why?
|
| Fatigue | 1 | 2002 | 365 | 0.040 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2002 | 238 | 0.040 |
Why?
|
| Mammals | 2 | 1998 | 286 | 0.040 |
Why?
|
| Evolution, Molecular | 3 | 2013 | 494 | 0.040 |
Why?
|
| Arabidopsis | 1 | 1999 | 94 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 3 | 1992 | 187 | 0.040 |
Why?
|
| Carrier Proteins | 2 | 2003 | 729 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2015 | 2399 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 1777 | 0.030 |
Why?
|
| Proteins | 3 | 2004 | 1023 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 1986 | 2050 | 0.030 |
Why?
|
| Peptide Initiation Factors | 1 | 1997 | 16 | 0.030 |
Why?
|
| Dogs | 1 | 1999 | 478 | 0.030 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 1997 | 32 | 0.030 |
Why?
|
| Mediator Complex | 1 | 1998 | 61 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 1997 | 92 | 0.030 |
Why?
|
| Tretinoin | 2 | 1990 | 125 | 0.030 |
Why?
|
| SAM Domain and HD Domain-Containing Protein 1 | 1 | 2017 | 12 | 0.030 |
Why?
|
| Burkitt Lymphoma | 2 | 1988 | 61 | 0.030 |
Why?
|
| Cell Survival | 1 | 2020 | 1103 | 0.030 |
Why?
|
| Spodoptera | 1 | 1997 | 40 | 0.030 |
Why?
|
| South Africa | 1 | 2018 | 266 | 0.030 |
Why?
|
| Prognosis | 2 | 2022 | 4329 | 0.030 |
Why?
|
| Alleles | 2 | 2013 | 896 | 0.030 |
Why?
|
| Exercise Therapy | 1 | 2002 | 475 | 0.030 |
Why?
|
| Melanocyte-Stimulating Hormones | 1 | 1996 | 3 | 0.030 |
Why?
|
| Receptors, Pituitary Hormone | 1 | 1996 | 2 | 0.030 |
Why?
|
| Drosophila | 1 | 1998 | 166 | 0.030 |
Why?
|
| Xeroderma Pigmentosum Group D Protein | 1 | 1996 | 6 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2017 | 369 | 0.030 |
Why?
|
| Melanocytes | 1 | 1996 | 65 | 0.030 |
Why?
|
| Sp1 Transcription Factor | 1 | 1996 | 24 | 0.030 |
Why?
|
| Pediatrics | 1 | 2024 | 1125 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 1996 | 68 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2017 | 336 | 0.030 |
Why?
|
| Herpes Simplex Virus Protein Vmw65 | 1 | 1995 | 6 | 0.030 |
Why?
|
| Critical Care | 1 | 2022 | 702 | 0.030 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 1995 | 28 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2021 | 1897 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2017 | 616 | 0.030 |
Why?
|
| Simplexvirus | 1 | 1995 | 82 | 0.030 |
Why?
|
| Mutation Rate | 1 | 2015 | 35 | 0.030 |
Why?
|
| Loss of Heterozygosity | 1 | 2015 | 52 | 0.030 |
Why?
|
| Apoptosis | 2 | 2017 | 2443 | 0.030 |
Why?
|
| DNA Primase | 1 | 2015 | 47 | 0.030 |
Why?
|
| Trastuzumab | 1 | 2015 | 118 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2015 | 106 | 0.030 |
Why?
|
| Imatinib Mesylate | 1 | 2015 | 77 | 0.030 |
Why?
|
| Tamoxifen | 1 | 2015 | 193 | 0.030 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2015 | 74 | 0.030 |
Why?
|
| Dacarbazine | 1 | 2015 | 100 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2015 | 53 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2015 | 72 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2015 | 53 | 0.030 |
Why?
|
| Blotting, Western | 1 | 1997 | 1184 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1994 | 48 | 0.030 |
Why?
|
| TATA Box | 1 | 1994 | 20 | 0.030 |
Why?
|
| Estrogens | 1 | 2017 | 367 | 0.030 |
Why?
|
| Lentivirus | 1 | 2014 | 61 | 0.030 |
Why?
|
| Male | 6 | 2021 | 73003 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2015 | 305 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2014 | 36 | 0.030 |
Why?
|
| Uniparental Disomy | 1 | 2014 | 9 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 936 | 0.030 |
Why?
|
| Quinazolines | 1 | 2015 | 266 | 0.030 |
Why?
|
| NAV1.2 Voltage-Gated Sodium Channel | 1 | 2014 | 8 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2014 | 13 | 0.030 |
Why?
|
| Histone Deacetylase 1 | 1 | 2014 | 23 | 0.030 |
Why?
|
| KCNQ2 Potassium Channel | 1 | 2014 | 15 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 311 | 0.030 |
Why?
|
| Granulosa Cell Tumor | 1 | 2013 | 6 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2014 | 25 | 0.030 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2014 | 31 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2013 | 21 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2015 | 421 | 0.020 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2013 | 47 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2015 | 427 | 0.020 |
Why?
|
| Mediator Complex Subunit 1 | 1 | 2013 | 6 | 0.020 |
Why?
|
| Family | 1 | 2018 | 685 | 0.020 |
Why?
|
| Gene Expression | 1 | 2018 | 1478 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 371 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2013 | 61 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2015 | 202 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2013 | 177 | 0.020 |
Why?
|
| Molecular Weight | 2 | 1990 | 312 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2021 | 11868 | 0.020 |
Why?
|
| Piperazines | 1 | 1995 | 375 | 0.020 |
Why?
|
| HIV | 1 | 1994 | 251 | 0.020 |
Why?
|
| Genetics, Medical | 2 | 2004 | 23 | 0.020 |
Why?
|
| Base Composition | 2 | 2004 | 82 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 334 | 0.020 |
Why?
|
| Gene Duplication | 2 | 2004 | 66 | 0.020 |
Why?
|
| Multimodal Imaging | 1 | 2013 | 129 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2013 | 108 | 0.020 |
Why?
|
| CpG Islands | 2 | 2004 | 171 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2012 | 295 | 0.020 |
Why?
|
| Immunoglobulin Light Chains | 2 | 1982 | 52 | 0.020 |
Why?
|
| Exome | 1 | 2013 | 229 | 0.020 |
Why?
|
| Cosmids | 1 | 1991 | 8 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1991 | 85 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 376 | 0.020 |
Why?
|
| Tomography, Optical Coherence | 1 | 2013 | 270 | 0.020 |
Why?
|
| Cytochrome b Group | 1 | 1991 | 22 | 0.020 |
Why?
|
| Plant Proteins | 2 | 2003 | 111 | 0.020 |
Why?
|
| Young Adult | 2 | 2021 | 14251 | 0.020 |
Why?
|
| Dinucleoside Phosphates | 1 | 1991 | 31 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 1991 | 78 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 383 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2014 | 668 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 848 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 1990 | 77 | 0.020 |
Why?
|
| Middle Aged | 3 | 2021 | 36302 | 0.020 |
Why?
|
| Organoplatinum Compounds | 1 | 2010 | 65 | 0.020 |
Why?
|
| Capecitabine | 1 | 2010 | 56 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2017 | 1329 | 0.020 |
Why?
|
| NADPH Oxidases | 1 | 1990 | 122 | 0.020 |
Why?
|
| DNA Transposable Elements | 2 | 2001 | 124 | 0.020 |
Why?
|
| Point Mutation | 2 | 2003 | 241 | 0.020 |
Why?
|
| Melanoma | 1 | 1996 | 761 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2017 | 2514 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2013 | 635 | 0.020 |
Why?
|
| Zebrafish | 1 | 2014 | 532 | 0.020 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2009 | 18 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2013 | 1191 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 1989 | 185 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 1857 | 0.020 |
Why?
|
| Gene Library | 1 | 2009 | 122 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 1988 | 53 | 0.020 |
Why?
|
| Kidney | 1 | 1996 | 1496 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 1150 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2009 | 247 | 0.020 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 1988 | 41 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3634 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 1987 | 120 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 751 | 0.020 |
Why?
|
| Disease Progression | 1 | 2015 | 2865 | 0.020 |
Why?
|
| Protein Biosynthesis | 2 | 1988 | 452 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2007 | 39 | 0.020 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2007 | 43 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 298 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2009 | 258 | 0.020 |
Why?
|
| Deoxyribonucleases | 1 | 1986 | 24 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2009 | 318 | 0.010 |
Why?
|
| Antibodies, Phospho-Specific | 1 | 2006 | 2 | 0.010 |
Why?
|
| Symbiosis | 1 | 2007 | 72 | 0.010 |
Why?
|
| DNA Damage | 1 | 2009 | 437 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2007 | 392 | 0.010 |
Why?
|
| Lymphoma | 1 | 1986 | 241 | 0.010 |
Why?
|
| Neutrophils | 1 | 1990 | 1125 | 0.010 |
Why?
|
| Contig Mapping | 1 | 2004 | 9 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 8346 | 0.010 |
Why?
|
| Pseudogenes | 1 | 2004 | 20 | 0.010 |
Why?
|
| Pan troglodytes | 1 | 2004 | 62 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2007 | 574 | 0.010 |
Why?
|
| Co-Repressor Proteins | 1 | 2003 | 18 | 0.010 |
Why?
|
| Aged | 2 | 2017 | 26215 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2003 | 59 | 0.010 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2003 | 12 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2014 | 6032 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 273 | 0.010 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2002 | 15 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2003 | 202 | 0.010 |
Why?
|
| Chromosomes, Human, 1-3 | 1 | 1982 | 3 | 0.010 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1982 | 23 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2003 | 199 | 0.010 |
Why?
|
| Ecosystem | 1 | 2007 | 478 | 0.010 |
Why?
|
| COS Cells | 1 | 2002 | 177 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2002 | 43 | 0.010 |
Why?
|
| HT29 Cells | 1 | 2002 | 37 | 0.010 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2002 | 93 | 0.010 |
Why?
|
| Adolescent | 1 | 2021 | 22573 | 0.010 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 2002 | 69 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 399 | 0.010 |
Why?
|
| Bacteriophage lambda | 1 | 1982 | 90 | 0.010 |
Why?
|
| GC Rich Sequence | 1 | 2001 | 4 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2003 | 239 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 979 | 0.010 |
Why?
|
| Public Sector | 1 | 2001 | 16 | 0.010 |
Why?
|
| Private Sector | 1 | 2001 | 50 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1986 | 872 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2002 | 319 | 0.010 |
Why?
|
| Drug Industry | 1 | 2001 | 49 | 0.010 |
Why?
|
| DNA Replication | 1 | 2002 | 249 | 0.010 |
Why?
|
| Physical Fitness | 1 | 2002 | 207 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2001 | 244 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2002 | 311 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2007 | 968 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 2002 | 544 | 0.010 |
Why?
|
| Species Specificity | 1 | 2001 | 546 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2015 | 11793 | 0.010 |
Why?
|
| Phylogeny | 1 | 2003 | 917 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2002 | 1001 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2003 | 523 | 0.010 |
Why?
|
| Chromosomes | 1 | 1999 | 106 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1986 | 688 | 0.010 |
Why?
|
| Heterochromatin | 1 | 1999 | 66 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1999 | 387 | 0.010 |
Why?
|
| Multigene Family | 1 | 1999 | 210 | 0.010 |
Why?
|
| Forecasting | 1 | 2001 | 390 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 2028 | 0.010 |
Why?
|
| Exercise Test | 1 | 2002 | 630 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2002 | 719 | 0.010 |
Why?
|
| Cloning, Organism | 1 | 1998 | 7 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 1998 | 21 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 1998 | 72 | 0.010 |
Why?
|
| Cations, Divalent | 1 | 1998 | 48 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 1998 | 89 | 0.010 |
Why?
|
| Heart Rate | 1 | 2002 | 856 | 0.010 |
Why?
|
| Quality of Life | 1 | 2010 | 3210 | 0.010 |
Why?
|
| Fetus | 1 | 1982 | 804 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1998 | 376 | 0.010 |
Why?
|
| Rats | 1 | 2006 | 5585 | 0.010 |
Why?
|
| Latex | 1 | 1996 | 9 | 0.010 |
Why?
|
| Nylons | 1 | 1996 | 24 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1999 | 938 | 0.010 |
Why?
|
| Microspheres | 1 | 1996 | 142 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1996 | 196 | 0.010 |
Why?
|
| Melanoma, Experimental | 1 | 1996 | 109 | 0.010 |
Why?
|
| Proteome | 1 | 2001 | 513 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2001 | 1491 | 0.010 |
Why?
|
| Cell Cycle | 1 | 1996 | 598 | 0.010 |
Why?
|
| Liver | 1 | 1982 | 1899 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2001 | 3416 | 0.010 |
Why?
|
| Skin | 1 | 1996 | 754 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1991 | 81 | 0.010 |
Why?
|
| Exercise | 1 | 2002 | 2205 | 0.000 |
Why?
|
| Reference Values | 1 | 1991 | 798 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2002 | 8075 | 0.000 |
Why?
|
| Pregnancy | 1 | 1982 | 7215 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1988 | 48 | 0.000 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 1987 | 28 | 0.000 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 1987 | 23 | 0.000 |
Why?
|
| Codon | 1 | 1988 | 92 | 0.000 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 1987 | 39 | 0.000 |
Why?
|
| Chickens | 1 | 1988 | 179 | 0.000 |
Why?
|
| Biological Evolution | 1 | 1988 | 468 | 0.000 |
Why?
|